Why is Vanguard Australian Shares Index ETF (ASX:VAS) performing so poorly?
Is the VAS ETF doing poorly? Why is Vanguard Australian Shares Index ETF (ASX: VAS) performing so poorly?
Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Is the VAS ETF doing poorly? Why is Vanguard Australian Shares Index ETF (ASX: VAS) performing so poorly?
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is down after shelving its plans to list in the United States.
The Fisher & Paykel Healthcare Corporation Ltd (ASX:FPH) share price has soared 6% in response to the FY24 result.
Resmed Inc (ASX: RMD) reported Q3 earnings overnight, on Thursday 25 April, sending RMD shares in its US up +11% after-hours.
The Resmed (ASX:RMD) share price has climbed 7% after the ASX healthcare share revealed its performance for the three months to March 2024.
The S&P/ASX 200 (INDEXASX: XJO) caught up with the global pullback last week, with a loss of 2.8%.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.81% to 7,612.
The S&P/ASX 200 (INDEXASX: XJO) pulled back 1.6% last week in line with global trends -while bond yields edged higher.
The S&P/ASX 200 (INDEXASX: XJO) delivered another positive day, gaining 0.3 per cent ahead of key US inflation data.
Is the VAS ETF doing poorly? Why is Vanguard Australian Shares Index ETF (ASX: VAS) performing so poorly?
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is down after shelving its plans to list in the United States.
The Fisher & Paykel Healthcare Corporation Ltd (ASX:FPH) share price has soared 6% in response to the FY24 result.
Resmed Inc (ASX: RMD) reported Q3 earnings overnight, on Thursday 25 April, sending RMD shares in its US up +11% after-hours.
The Resmed (ASX:RMD) share price has climbed 7% after the ASX healthcare share revealed its performance for the three months to March 2024.
The S&P/ASX 200 (INDEXASX: XJO) caught up with the global pullback last week, with a loss of 2.8%.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.81% to 7,612.
The S&P/ASX 200 (INDEXASX: XJO) pulled back 1.6% last week in line with global trends -while bond yields edged higher.
The S&P/ASX 200 (INDEXASX: XJO) delivered another positive day, gaining 0.3 per cent ahead of key US inflation data.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.